Treatment Of Chronic Pain Using Real Time fMRI
1 other identifier
interventional
144
1 country
1
Brief Summary
The purpose of this study is to test a new investigational method for treatment of chronic pain using cognitive training guided by functional magnetic resonance imaging (fMRI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2 chronic-pain
Started Sep 2007
Typical duration for phase_2 chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 11, 2007
CompletedFirst Posted
Study publicly available on registry
September 12, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedApril 26, 2011
April 1, 2011
3.9 years
September 11, 2007
April 25, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measures of Pain Magnitude; McGill Pain Questionnaire; Visual Analogue Scale; Coping Strategies; Pain Catastrophizing Scale; Beck Depression Inventory; Treatment Outcome of Pain States; Increased control over brain activation measured using fMRI
duration of the trial
Study Arms (2)
1
ACTIVE COMPARATORParticipants will see their own brain activation.
2
PLACEBO COMPARATORParticipants will see simulated data that does not come from their own brains.
Interventions
Participants will be scanned using fMRI while they employ the cognitive training strategies-allowing them to view their brain activity.
Some participants will see simulated data that does not come from their own brains.
Eligibility Criteria
You may qualify if:
- Clinically diagnosed chronic pain. Some example diagnoses include: CRPS, RSD, neuropathy, neuralgia, fibromyalgia, or migraine.
- No implanted medical devices that are not compatible with MRI (spinal cord stimulator/pump, pacemaker, surgical aneurysm clip, etc)
- No recent history of severe psychiatric illness
- Weight less than 220 lbs.
- Able to be scanned in MRI without claustrophobia
- No facial tattoos, non-removable metal implants, piercings, or extensive dental work.
- Not pregnant or having fertility treatments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Omneuron, 99 El Camino Real
Menlo Park, California, 94025, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher deCharms, PhD
Omneuron
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 11, 2007
First Posted
September 12, 2007
Study Start
September 1, 2007
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
April 26, 2011
Record last verified: 2011-04